There is a United Kingdom-wide “Pharmaceutical Price Regulation Scheme”
controlling the pricing of non-generic drugs purchased by the NHS throughout
the United Kingdom, with profit limits for companies and an overall cap on
expenditure. Several patient empowerment strategies are in place, including
specific rights for patients.